Vanda Pharmaceuticals
VNDA
$4.78
Share price
3.35%
Change (1 day)
-22.23%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Net assets
Net assets on the balance sheet as of December 2023 : $0.54 B
According to Vanda Pharmaceuticals's latest financial reports the company has $0.54 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.54 B | 3.36% |
| 2022-12-31 | $0.52 B | 4.41% |
| 2021-12-31 | $0.50 B | 11.4% |
| 2020-12-31 | $0.45 B | 10.3% |
| 2019-12-31 | $0.41 B | 49.21% |
| 2018-12-31 | $0.27 B | 109.63% |
| 2017-12-31 | $0.13 B | 0.04% |
| 2016-12-31 | $0.13 B | -1.28% |
| 2015-12-31 | $0.13 B | -17.28% |
| 2014-12-31 | $0.16 B | 264.47% |
| 2013-12-31 | $44.12 M | 345.47% |
| 2012-12-31 | $9.9 M | -70.41% |
| 2011-12-31 | $33.47 M | -11.28% |
| 2010-12-31 | $37.73 M | 63.83% |
| 2009-12-31 | $23.03 M | -49.95% |
| 2008-12-31 | $46.02 M | -45.04% |
| 2007-12-31 | $83.72 M | 212.92% |
| 2006-12-31 | $26.75 M | -12.74% |
| 2005-12-31 | $30.66 M | 92.33% |
| 2004-12-31 | $15.94 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 12,521.17% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 7,195.88% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 16,285.83% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 1,893.67% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 6,806.65% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 2,936.83% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | $6.64 M | -98.78% | 🇺🇸 USA |